Found 7 clinical trials
A Clinical Study to Develop a Controlled Human Infection Model Using Leishmania Major-infected Sand Flies (LEISHChallenge)
leishmaniasis which can affect the skin (cutaneous leishmaniasis) or the internal organs of the body (visceral leishmaniasis). Some of the milder forms will produce skin problems which will be localised, whilst
- 0 views
- 22 Mar, 2022
- 1 location
LAMP Assay for the Diagnosis of Visceral Leishmaniasis (EvaLAMP)
This study will evaluate the of the loop-mediated amplification assay (LAMP) as a diagnostic as well as a Test-of-Cure (ToC) for visceral leishmaniasis (VL) in an endemic area in Ethiopia
- 0 views
- 11 Feb, 2022
- 1 location
A Study to Assess Immune Response Status in Patients Before and After Treatment for Visceral Leishmaniasis
ImmStat@Cure is a multicentre observational study designed to assess the immune status of patients before and after treatment for visceral leishmaniasis. Forty patients and 30 controls will be
- 0 views
- 30 May, 2022
- 1 location
Evaluation of Less Invasive Procedures for Visceral Leishmaniasis Treatment Efficacy Monitoring Test of Cure (VL-ToC)
Left untreated, visceral leishmaniasis (VL) is fatal. The highest burden of VL worldwide is in eastern Africa where field-adapted diagnostic and test-of-cure tools and treatment are lacking. The
- 0 views
- 02 Jul, 2022
Mediterranean Visceral Leishmaniasis With Leishmania Infantum
the factors associated with the development of visceral leishmaniasis.
- 0 views
- 26 Jan, 2021
- 1 location
Real World Study of Classic Infectious Disease
diseases (brucellosis, epidemic hemorrhagic fever, kala-azar) and treatment options suitable for China.
- 2 views
- 12 Feb, 2022
- 1 location
Diagnosis and Treatment of Leishmania Infections
mucocutaneous leishmaniasis and visceral leishmaniasis will be followed every 3 to 6 months indefinitely for routine evaluations and re-treatment if the infection recurs. ...
- 21 views
- 01 Jul, 2022
- 1 location